+1 650 843 5896 khillier@cooley.com
Dr. Kate Hillier's practice focuses on the representation of public and private life sciences companies discovering, developing and marketing biopharmaceutical, vaccine, medical device, diagnostic and digital health products.
Download full bio
Cell Design Labs Sells to Gilead
Cell Design Labs: Collaboration Agreement with Kite Pharma and Simultaneous Series of Private Financings
23andMe in its Multi-year Collaboration with GSK
Vir Biotechnology - $143 Million IPO
Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion
View all
Life Sciences
Life Sciences Corporate Partnering & Licensing
Cambridge University (Jesus College)JD, with First Class honors, 2005
Oxford Institute of Legal PracticeDiploma in Legal Practice, with distinction, 2005
Australian and New Zealand College of AnaesthetistsFellowship, 2002
University of Adelaide, AustraliaMBBS (Medicine and Surgery), with distinction1996
California
England & Wales
Merus Enters Collaboration With Eli Lilly to Develop New Generation of Cancer Treatments February 3, 2021
CStone Completes $200 Million Share Sale to Pfizer, Launches Strategic Collaboration October 29, 2020
Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion August 18, 2020
State Bar of California
Solicitors Regulation Authority in the United Kingdom
Legal 500: Next Generation Partner, Healthcare: Life Sciences
+1 650 843 5896 office khillier@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130